UnknownNot Applicable

EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTS

Turkey (Türkiye)30 participantsStarted 2023-08-01

Plain-language summary

Observation of the effects of cytokine adsorbent hemadsorption therapy on hemodynamics and mortality in critically ill patients who developed vasoplegic shock due to hyperinflammation without microbiological findings in the intensive care unit.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * C-reactive protein (CRP) ≥ 100 mg/l * Procalcitonin (PCT) \< 2 ng/l * Patients aged 18-80 years who were treated with cytokine adsorption due to vasoplegic shock Exclusion Criteria: * Patients under 18 years of age * Patients with suspected or proven bacterial cause of vasoplegic shock. * Those who did not approve to participate in the study * Patients without vasoplegic shock * Patients with CRP \< 100 mg/l, PCT ≥ 2 μg/L

What they're measuring

The time to resolution of vasoplegic shock within days.

Timeframe: From enrollment to the end of treatment at 12 weeks

Trial details

NCT IDNCT05984407

SponsorHakan Küçükkepeci

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-01

View on ClinicalTrials.gov More Cytokine Hemadsorption Therapy in Critically Ill Patients Who Have no Microbiological Findings and Develop Vasoplegic Shock trials